Rambam Health Care Campus
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 1938-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.rambam.org.il
The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory Control
- First Posted Date
- 2008-04-17
- Last Posted Date
- 2017-10-11
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 64
- Registration Number
- NCT00660751
- Locations
- 🇮🇱
Rambam Health Care Campus, Haifa, Israel
Interventional Trial of Vitamin D Deficiency in the Patients of General Departments
Phase 3
- Conditions
- Vitamin D Deficiency
- Interventions
- Dietary Supplement: Alpha-D3
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2008-03-21
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 300
- Registration Number
- NCT00640237
- Locations
- 🇮🇱
Rambam Health Care Campus, Haifa, Israel
Efficacy of a New Topical Anesthetic
- First Posted Date
- 2007-11-21
- Last Posted Date
- 2014-05-06
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 40
- Registration Number
- NCT00562211
- Locations
- 🇮🇱
Emergency Department of the Meyer Children Hospital, Rambam Health Care Campus, Haifa, Israel
Spirometry and Methacholine Challenge Test in Asthmatic Children Age 3-6years
Not Applicable
Terminated
- Conditions
- AsthmaRecurrent Cough
- First Posted Date
- 2007-10-30
- Last Posted Date
- 2007-10-30
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 84
- Registration Number
- NCT00550758
Antibodies to Digoxin for Bipolar Disorder
Phase 2
Completed
- Conditions
- Bipolar Disorder
- Interventions
- Drug: Digibind (Fab)
- First Posted Date
- 2007-10-30
- Last Posted Date
- 2013-06-11
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 18
- Registration Number
- NCT00550576
- Locations
- 🇮🇱
Rambam Health Care Campus, Haifa, Israel
Drug Utilization Prevalence in a Pediatric Care Medical Center
Completed
- Conditions
- Metabolic DiseasesInfectious DiseasesCancer
- First Posted Date
- 2007-10-30
- Last Posted Date
- 2013-06-11
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 567
- Registration Number
- NCT00550706
- Locations
- 🇮🇱
Rambam Health Care Campus, Haifa, Israel
Urinary Sensor for Cystourethrography
Not Applicable
Completed
- Conditions
- Radiation Dose During VCUG
- Interventions
- Device: Urinary sensorOther: placebo
- First Posted Date
- 2007-10-23
- Last Posted Date
- 2009-10-28
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 20
- Registration Number
- NCT00547820
- Locations
- 🇮🇱
Department of Diagnostic Imaging, Rambam Health Care Campus, Haifa, Israel
Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.
Phase 2
Completed
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Drug: Mistletoe extract
- First Posted Date
- 2007-08-14
- Last Posted Date
- 2011-09-27
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 79
- Registration Number
- NCT00516022
- Locations
- 🇮🇱
Rambam Medical Center, Haifa, Israel
Antidepressant Effect of Theta-Burst rTMS
Phase 2
- Conditions
- Major Depression
- First Posted Date
- 2007-08-14
- Last Posted Date
- 2007-08-14
- Lead Sponsor
- Rambam Health Care Campus
- Registration Number
- NCT00515658
- Locations
- 🇮🇱
Rambam Medical Center, Haifa, Israel
The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma
Withdrawn
- Conditions
- Lymphoma; Large Cell (Diffuse) With Small Cell, Diffuse
- First Posted Date
- 2007-07-10
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Rambam Health Care Campus
- Registration Number
- NCT00498667
- Locations
- 🇮🇱
RAMBAM health care Campus, Haifa, Israel